60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05571332 (ClinicalTrials.gov)	June 28, 2022	28/8/2022	Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnorma ...	Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnorma ...	Aplastic Anemia	Drug: Avatrombopag 20 MG Oral Tablet	Institute of Hematology & Blood Diseases Hospital	NULL	Recruiting	18 Years	70 Years	All	39	N/A	China
2	NCT04728789 (ClinicalTrials.gov)	February 1, 2021	1/12/2020	Avatrombopag Usage in NSAA	Efficacy and Safety of Avatrombopag in Non-severe Aplastic Anemia - a Multicenter Prospective Single ...	Aplastic Anemia;Drug Effect	Drug: Avatrombopag 20 MG	Peking Union Medical College Hospital	NULL	Not yet recruiting	18 Years	75 Years	All	40	Phase 2/Phase 3	China

First Previous1Next Last